NEW YORK, Sept. 23 (GenomeWeb News) - Perlegen Sciences said that Eli Lilly will increase its funding in support of the companies' ongoing pharmacogenomics research collaboration.

Under the partnership, which was struck in Dec. 2002, Perlegen is using its proprietary technology to genotype SNPs in clinical samples and discover genetic markers for Lilly.

Perlegen said that the increased funding is in addition to milestones and payments Lilly is making under the original deal.

Specific terms of the arrangement remain undisclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.